Graf Acquisition
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch GFOR and buy or sell other stocks, options, and ETFs commission-free!About GFOR
NKGen Biotech, Inc. is a clinical-stage biotechnology company, which focuses on the development and commercialization of innovative autologous, allogeneic, and CAR-NK cell therapies utilizing a proprietary SNK platform. Its product candidates are based on a proprietary manufacturing and cryopreservation process which produces SNK cells that have high potency as defined by parameters such as cytotoxicity, cytokine production, and activating receptor expression.
CEOPaul Song, MD, PhD
CEOPaul Song, MD, PhD
Employees63
Employees63
HeadquartersSanta Ana, California
HeadquartersSanta Ana, California
Founded
Founded
Employees63
Employees63
GFOR Key Statistics
Market cap35.24M
Market cap35.24M
Price-Earnings ratio-0.39
Price-Earnings ratio-0.39
Dividend yield—
Dividend yield—
Average volume4.50M
Average volume4.50M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$12.88
52 Week high$12.88
52 Week low$0.7802
52 Week low$0.7802